Physician profile
Joseph Robert Harmon
NPI 1265865885
$2,696.61
in general payments reported to CMS, 2019-2025
12 companies · $2,089 in 2025
The $2,089 reported for 2025 was more than what 95% of Obstetrics providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $129 · 2020: $118 · 2021: $198 · 2022: $11.81 · 2023: $79.59 · 2024: $71.63 · 2025: $2,089.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,846 · Food and Beverage: $394.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,846.25 |
| Food and Beverage | $393.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $2,126.40 | 2023-2025 | Altis |
| Abbvie INC. | $249.57 | 2019-2024 | |
| Intuitive Surgical, INC. | $59.53 | 2019 | |
| Daiichi Sankyo INC. | $44.86 | 2020 | |
| Aspira Women'S Health INC | $43.08 | 2021 | |
| Hologic Sales and Service, LLC | $35.71 | 2019-2021 | |
| Roche Diagnostics Corporation | $31.83 | 2019 | |
| Therapeuticsmd, INC. | $27.03 | 2020-2021 | |
| Organon LLC | $25.97 | 2025 | Jada System |
| Minerva Surgical, INC | $18.90 | 2025 | |
| Novo Nordisk INC | $17.38 | 2020 | |
| Exeltis, USA INC. | $16.35 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Harmon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.